NEDA 3 and 4 ‘hard to achieve’ with relapsing MS, real-world study finds
Achieving NEDA ā no evidence of disease activity ā after two years of treatment was not common among people with relapsing-remitting multiple sclerosis (RRMS) at a center in Italy. NEDA more often was reached, however, when researchers didn’t include the first few months of treatment in their analysis, suggesting…